Schulungsvideos und Webinare zu Deflux und zum vesikoureteralen Reflux

Palette Life Sciences präsentiert Ihnen Schulungsvideos und Webinare mit nützlichen Informationen zur Kinderurologie, zum vesikoureteralen Reflux und den Best Practices für Deflux. Die Materialien in diesen Videos basieren auf persönlichen Erfahrungen und Erkenntnissen des/der Referenten.

Educational videos

Deflux Syringe & Metal Needle Preparation & Assembly
Learn how to properly assemble the Deflux Syringe & Metal Needle, in preparation for performing the Deflux procedure.
Grading VUR
Resource available for physician download, for use in educational presentations.
Deflux Injection Technique with Dr. Kirsch
In this video, Andrew Kirsch, MD, covers the correction of VUR using the Double Hydrotistension Implantation Technique (HIT).
Note: Deflux is indicated for vesicoureteral reflux (VUR) in children. Please see complete Prescribing Information for DEFLUX here.

On-demand webinars

Individualized Approach to Treating VUR
Individualized Approach to Treating VUR
In this webinar, Dr. Marie-Klaire Farrugia discusses her individualized approach to treating children with VUR   Marie-Klaire Farrugia MD, MD(Res), FRCSEd(Paed Surg) Chelsea and Westminster and Imperial College Hospitals, London.

Note: Deflux is indicated for children with vesicoureteral reflux grades. Please see complete Prescribing Information for DEFLUX here.

Tips for Using Deflux to Successfully Treat Grade IV VUR
Tips for Using Deflux to Successfully Treat Grade IV VUR
In this webinar, Dr. Andrew Kirsch discusses success rates in treating VUR endoscopically, including in Grade IV cases.

Andrew Kirsch, M.D.
Board-Certified Pediatric Urologist
Professor & Chief of Pediatric Urology
Emory University School of Medicine

Note: Deflux is indicated for children with vesicoureteral reflux grades II-IV. Please see complete Prescribing Information for DEFLUX here.

Become an Expert with Deflux
Become an Expert with Deflux
Hosted by Drs. Andrew Kirsch and Angela Arlen, this webinar focuses on endoscopic injection technique with Deflux for the treatment of vesicoureteral reflux (VUR).

Andrew Kirsch, M.D.
Board-Certified Pediatric Urologist
Professor & Chief of Pediatric Urology
Emory University School of Medicine

Angela Arlen, M.D.
Board-Certified Pediatric Urologist
Assistant Professor of Urology
Yale New Haven Hospital

Note: Deflux is indicated for children with vesicoureteral reflux grades II-IV. Please see complete Prescribing Information for DEFLUX here.

International Approach to VCUG Technique and Reporting (UK & EU)
International Approach to VCUG Technique and Reporting (UK & EU)
In this webinar, Dr. Marie-Klaire Farrugia and Dr. Dominic Frimberger lecture about what information should be collected from a VCUG and how to get those results from your colleagues in radiology and pediatrics.

Marie-Klaire Farrugia
MD, MD(Res), FRCSEd(Paed Surg)
Chelsea and Westminster and Imperial College Hospitals, London.

Dr. Dominic Frimberger
Board Certified Pediatric Urologist
Children's Hospital of Oklahoma

Note: Deflux is indicated for children with vesicoureteral reflux grades II-IV. Please see complete Prescribing Information for DEFLUX here.

Let's Talk Reflux: Thoughtful Strategies in Diagnosis and Management
Let's Talk Reflux: Thoughtful Strategies in Diagnosis and Management
Optimal vesicoureteral reflux remains controversial. Guidelines for patient selection regarding diagnosis and management require the application of an individual approach for shared decision making. Our course examines the challenges faced by the patient, the caregiver and you, the surgeon.

Dr. Andrew J. Kirsch
MD, FAAP, FACS
Georgia Urology

Dr. Angela Arlen
Board-Certified Pediatric Urologist
Yale New Haven Hospital

Note: Deflux is indicated for children with vesicoureteral reflux grades II-IV. Please see complete Prescribing Information for DEFLUX here.

The Modern Management of VUR: The Importance of Risk Stratification
The Modern Management of VUR: The Importance of Risk Stratification
Dr. Antoine Khoury, Board-Certified Pediatric Urologist at CHOC Children's Urology Center, discusses the importance of risk stratification in managing vesicoureteral reflux (VUR). This talk was given at the Societies for Pediatric Urology's 2020 virtual meeting.

Note: Deflux is indicated for vesicoureteral reflux (VUR) in children. Please see complete Prescribing Information for DEFLUX here.

Advanced Technique: Deflux Injection Training
Advanced Technique: Deflux Injection Training
Hosted by Dr. Andrew Kirsch, this webinar focuses on advancing endoscopic injection technique with Deflux for the treatment of vesicoureteral reflux (VUR). Webinar length is 90 minutes.

Note: Deflux is indicated for children with vesicoureteral reflux grades II-IV. Please see complete Prescribing Information for DEFLUX here.

<nobr>Deflux Injection Training Part 1</nobr>
Deflux Injection Training Part 1
In the first half of this two-part series, Chief of Pediatric Urology for Georgia Urology, Andrew Kirsch, MD, and Chief, Duke University Medical Center for Children’s Surgery, Jonathan Routh, MD, discuss the clinical & surgical management of children with VUR, UTI & BBD, as well as how Deflux fits into their practice.

Note: Deflux is indicated for children with vesicoureteral reflux grades II-IV. Please see complete Prescribing Information for DEFLUX here.

<nobr>Deflux Injection Training Part 2</nobr>
Deflux Injection Training Part 2
In the second half of this two-part series, Dr. Andrew Kirsch and Dr. Jonathan Routh detail their injection techniques for treating VUR with Deflux, including the Double HIT Technique.

Note: Deflux is indicated for children with vesicoureteral reflux grades II-IV. Please see complete Prescribing Information for DEFLUX here.

Load more

Schulungsvideos

Melden Sie sich an, um E-Mails von Palette Life Sciences bezüglich der anstehenden Deflux-Webinare zu erhalten.

Hinweis: Deflux ist zur Behandlung des vesikoureteralen Reflux indiziert. Die vollständigen Verschreibungsinformationen für DEFLUX finden Sie hier.

Für Produktinformationen, Meldungen von Nebenwirkungen und Produktbeschwerde-Berichte wenden Sie sich bitte an:

Palette Life Sciences
Abteilung für medizinische Information- DE

DE: +49 0 800 1813 334
E-Mail: paletteeur@eversana.com

X